| Malignant Genitourinary System Neoplasm altered in cohorts of …ALTERED_INderived200 of 881show all (up to 200) |
|---|
| ← altered in cohorts of | COL7A1 450 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | GLB1 450 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLXNB1 450 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATRIP 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC51 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDC25A 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CELSR3 449 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXW12 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HHATL 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IP6K2 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCKIPSD 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PFKFB4 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKAR2A 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTH1R 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN5A 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHISA5 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC26A6 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMA7 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM89 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TREX1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UCN2 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UQCRC1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VIPR1 449 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14A-ACY1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD14B 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABHD5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ACY1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ALAS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANO10 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | APEH 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARIH2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BSN 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 4 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf62 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C3orf84 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CAMP 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC13 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC71 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCRL2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DAG1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DALRD3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCAF1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK3 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 3 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | DUSP7 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNAI2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR62 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPX1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IHO1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCF5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC8B 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL40 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMB2 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LARS2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIMD1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LTF 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MST1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDUFAF3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NICN1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NKTR 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NME6 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | P4HTM 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PARP3 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCBP4 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDCD6IP 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POC1A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTPN23 448 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts | — | — | Clear Cell Renal Cell Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | QARS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | QRICH1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL29 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RRP9 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN10A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCN11A 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC22C 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC25A20 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNRK 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPCS1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPINK8 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SS18L2 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SUSD5 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TCTA 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TLR9 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOPAZ1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP19 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP4 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR6 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XIRP1 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB47 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF589 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF620 448 / 536 cases (84 %) · ssm · TCGA-KIRC | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADRM1 45 / 57 cases (79 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GATA5 45 / 57 cases (79 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSMA7 45 / 57 cases (79 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AHSG 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARFGEF2 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A3 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CABLES2 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC11 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GP5 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HRH3 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KNG1 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LSM14B 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTG2 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OSBPL2 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBBP8NL 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPS21 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SS18L1 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STAU1 44 / 57 cases (77 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV5 43 / 57 cases (75 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ2 43 / 57 cases (75 %) · ssm · TCGA-UCS | — | — | Uterine Carcinosarcoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNIK 228 / 306 cases (75 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | BCHE 226 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN16 226 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | FNDC3B 226 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC7A14 226 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPATA16 226 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBL1XR1 226 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBBX 226 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCC5 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTRT3 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A5 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | BCL6 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN11 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPP 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC31 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC34 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYNN 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | P3H2 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | PEX5L 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLD1 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRKCI 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SEC62 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SKIL 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | TP63 225 / 306 cases (74 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | WDR49 225 / 306 cases (74 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCF3 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | ACTL6A 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP13A4 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | ECT2 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GHSR 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL1RAP 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | IQCG 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRIQ4 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MB21D2 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | MCF2L2 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MECOM 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | NCEH1 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OPA1 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PHC3 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | PSMD2 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SAMD7 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC2A2 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLITRK3 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM207 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFSF10 224 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VPS8 224 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | AP2M1 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC39 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRD 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DGKG 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF2B5 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF5A2 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGF12 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | GOLIM4 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR160 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HRG 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNMB2 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LIPH 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | MFN1 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MRPL47 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGZ 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | PLAAT1 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL22L1 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RUBCN 223 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | SERPINI2 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX2 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZMAT3 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF639 223 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADIPOQ 222 / 306 cases (73 %) · ssm · TCGA-CESC | — | — | Cervical Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCDC50 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CLDN1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | DLG1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1AKMT4-ECE2 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | EHHADH 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | EIF4G1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | GMNC 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3C 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3D 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR3E 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL24 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL6 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | LRCH3 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | LSG1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | MCCC1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | MELTF 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | NAALADL2 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | PYDC2 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 3 cohorts | — | — | Cervical Carcinoma | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | SERPINI1 222 / 306 cases (73 %) · ssm · TCGA-CESC · largest of 2 cohorts | — | — | Cervical Carcinoma | 2 | Observed | gdc | graph → |